NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Shattuck Labs, Inc. Common Stock Share Price Chart

O H L

Shattuck Labs, Inc. Common Stock Performance Overview

Days Range
$5.82Low
$6.17High

Markets Today

Previous Close$5.85
Open$5.82
Volume154,487
Day's Range$5.82 - $6.17
52W Range$1.70 - $8.33
Market Cap$590.14 M

Historical Performance

1M Returns-21.48
3M Returns+18.18
6M Returns-3.15
1Y Returns+162.33
5Y Returns-69.15
10Y ReturnsNA

Shattuck Labs, Inc. Common Stock Fundamentals

Market Cap$590.14 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$1.00 M
ROE TTM-0.60
EPS TTM$-0.51
Quarterly Earnings Growth YOYN/A
PB Ratio2.81
EBITDA$-47.82 M
Profit Margin-4880.90
Market Cap$590.14 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$1.00 M
ROE TTM-0.60
EPS TTM$-0.51
Quarterly Earnings Growth YOYN/A
PB Ratio2.81
EBITDA$-47.82 M
Profit Margin-4880.90

Shattuck Labs, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$1.00 M$0$0$0
Gross Profit +$0$0$1.00 M$0$0$0
Operating Income -$14.39 M-$13.03 M-$10.72 M-$13.37 M-$15.54 M-$16.16 M
EBITDA -$13.45 M-$12.10 M-$9.80 M-$12.46 M-$14.65 M-$15.30 M
Interest Expense $0$0$0$0$0$0
Depreciation $936.00 K$929.00 K$917.00 K$906.00 K$891.00 K$851.00 K
Income Before Tax -$13.70 M-$12.46 M-$10.06 M-$12.59 M-$14.77 M-$15.15 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$13.70 M-$12.46 M-$10.06 M-$12.59 M-$14.77 M-$15.15 M
Net Profit Margin ---1005.6%---

Shattuck Labs, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $5.00 K$5.00 K$7.00 K$7.00 K$7.00 K$10.00 K
Reserve & Surplus -$395.42 M-$407.88 M-$417.93 M-$430.52 M-$445.30 M-$460.51 M
Non-Current Liabilities $2.27 M$2.02 M$1.76 M$1.58 M$2.04 M$1.80 M
Current Liabilities $7.32 M$5.34 M$5.34 M$7.05 M$4.25 M$7.73 M
Total Liabilities $9.58 M$7.35 M$7.09 M$8.64 M$6.29 M$9.53 M
Fixed Assets $8.88 M$7.95 M$7.05 M$6.11 M$5.35 M$4.51 M
Current Assets $66.40 M$54.67 M$90.72 M$82.47 M$93.75 M$213.27 M
Total Assets $77.17 M$64.37 M$100.33 M$91.03 M$102.12 M$220.67 M

Shattuck Labs, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$13.70 M-$12.46 M-$10.06 M-$12.59 M-$14.77 M-$15.15 M
Operating Cash Flow -$12.03 M-$10.43 M-$8.93 M-$8.49 M-$13.42 M-$10.19 M
Investing Cash Flow $15.60 M$0-$43.49 M$20.00 M$23.85 M-$144.95 M
Financing Cash Flow -$57.00 K$0$44.50 M$134.00 K$25.80 M$128.01 M
Change in Cash $3.51 M-$10.43 M-$7.92 M$11.64 M$36.23 M-$27.12 M

Shattuck Labs, Inc. Common Stock Return Calculator

The Shattuck Labs, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$3,175
Invested Amount$10,000
Est. Returns$-6,825
Invest in USA Stock Today

About Shattuck Labs, Inc. Common Stock

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

FAQs

Shattuck Labs, Inc. Common Stock (STTK) share price as of September 18, 2026 is $6.02. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Shattuck Labs, Inc. Common Stock (STTK) Share by opening an international trading account with Angel One.
Purchasing Shattuck Labs, Inc. Common Stock (STTK) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Shattuck Labs, Inc. Common Stock (STTK) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Shattuck Labs, Inc. Common Stock (STTK) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Shattuck Labs, Inc. Common Stock on September 18, 2026, is $590.14 M.
Shattuck Labs, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Shattuck Labs, Inc. Common Stock (STTK) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91